関連する実験動画
Updated: Sep 10, 2025

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
348
肥満医学における薬剤類似薬: 知識に基づいた選択,適切な選択
Sanjay Kalra1, Amandeep Singh2, Nitin Kapoor3
1Department of Endocrinology, Bharti Hospital, Karnal, India; University Centre for Research& Development, Chandigarh University, Mohali, India.
JPMA. The Journal of the Pakistan Medical Association
|August 25, 2025
まとめ
セマグルチドのようなペプチドベースの肥満薬の区別は 曖昧になっています 新しい枠組みは様々な要因に基づいて 最適な抗肥満薬を 選択するのに役立ちます
科学分野:
- 内分泌薬理学
- 薬の開発
- 肥満に対する薬
背景:
- バイオシミラーとジェネリックの区別は,特にペプチドベースの薬の進化です.
- オリジナルのセマグルチドは生物学的であり,後のバージョンは合成ジェネリックです.
- チルゼパチドは合成ポリペプチドであり,分子タイプの変化を強調しています.
研究 の 目的:
- 抗肥満薬に関する情報に基づいた意思決定のための枠組みを提案する.
- バイオシミラーとジェネリックペプチドベースの薬の間の曖昧な境界を解決する.
- 薬剤の選択に関する情報の共有を促進する.
主な方法:
- 概念的枠組みの開発
- 薬の特性分析 (バイオシミラーとジェネリック,合成ペプチド)
- 薬の選択に影響を与える要因のレビュー
主要な成果:
- "薬剤同類"という用語は,バイオシミラーとペプチドベースのジェネリック医薬品の両方をカバーすることができます.
- 意思決定のための包括的な枠組みが提案されています.
- 薬の選択に影響を与える重要な要因には,承認状況,証拠ベース,経済,サプライチェーンが含まれます.
結論:
- 現代の抗肥満薬の複雑さを把握するには 構造的なアプローチが必要です
- 供給チェーンやコストといった 純粋な有効性以外の要因も重要です
- 提案された枠組みは,臨床医と患者が適切な治療法を選択するのに役立ちます.
関連する概念動画
Oral Hypoglycemic Agents: Biguanides and Glitazones
291
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
291
Obesity
612
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
612
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
256
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
256
Bioequivalence: Overview
1.2K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.2K
Prescription, Nonprescription and Orphan Drugs
844
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
844
Pharmacokinetic Models: Comparison and Selection Criterion
149
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
149

